Associate Director, Marketing GI, Europe

Das ist der Job

The company’s RD pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.

Darum lohnt es sich

As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. /p h3The Opportunity /h3pReporting to the Executive Director, Marketing GI, Europe, the Associate Director, Marketing GI, Europe will play an important role in supporting launch preparation activities for daraxonrasib and future GI compounds across Europe.

Working closely with Medical Affairs and Market Access teams, they will support the development of aligned positioning, communication strategies, and core messaging across Europe. /p pThe Associate Director will lead the execution of key marketing projects and the development of customer-facing materials, events, congress activities, campaigns, training resources, and field force tools that enhance engagement with healthcare professionals and key opinion leaders. /p pIn addition, he/she will collaborate with Market Access and Medical Affairs colleagues to ensure that customer, evidence, pricing, and reimbursement considerations are reflected in launch plans and tactical execution. /p ul liDevelop and execute comprehensive marketing tactics to drive European expansion and market penetration, and addressing identified hurdles opportunities to reach revenue and market share goals. /li liBuild brand/disease area tactical plans based on in-depth market analysis, competitive landscape assessments, and identify key trends to inform strategic decision-making. /li liImplement the European Marketing strategy through various programs/channels, e.g. events, webinars, digital promotion. /li liWork closely with internal team and external vendors to develop and produce efficacious promotional materials and activities. /li liSupport planning and execute European commercial congress presence to create awareness for Revolutionary Medicines, our products and support product launches. /li liPartner with national teams to support national launches and sales success in Europe. /li liEngage with HCPs to gather insights, validate commercial plans, and optimize marketing activities for best treatment benefit. /li liLeverage KOL relationships to enhance the company's scientific and commercial credibility in European markets. /li liRepresent the company at international conferences, industry events, and other meetings to promote our oncology products and company mission. /li liCollaborate closely with cross-functional teams including Medical, Market Access, Regulatory, Quality and Compliance and especially national teams to drive integrated plans. /li liLive the Revolution Medicines Values and be an example for the team. /li liDwell in an environment of creativity, out-of-the-box thinking and idea generation propelling our commercial success. /li /ul h3Required Skills, Experience and Education /h3 ul liAdvanced degree (MBA, PhD, MD, or equivalent) in a relevant field such as biotechnology, life sciences, or business administration. /li liMinimum of 8+ years of experience within the biotech or pharmaceutical industry in marketing, sales, or product planning with a focus on oncology. /li liExperience in successfully launching and commercializing products in European markets, with a preference for thorough experience in major markets, e.g.

Spain or Italy. /li liProven ability for collaborating with cross-functional teams in an international setting. /li liStrong analytical, and problem-solving skills, significant project management capabilities. /li liExcellent communication, customer interaction, presentation, and interpersonal skills. /li liProven ability to develop and maintain relationships with healthcare professionals. /li liAbility to translate deep scientific understanding and customer insights to creative promotional approaches. /li liWillingness to travel internationally as needed. /li liThrives in a highly dynamic, pragmatic and rapidly changing biotech environment, pragmatism to get things done. /li li#LI-Hybrid #LI-LO1 /li /ul /p #J-18808-Ljbffr ph3Overview /h3pRevolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.

The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.

Acting as a trusted and creative partner to the Executive Director, this individual will help shape and execute European marketing tactical plans and translate strategic priorities into impactful initiatives for local markets. /p pThe Associate Director will support the identification and assessment of market opportunities, customer needs, and treatment challenges across European markets, including healthcare system dynamics, competitive developments, diagnostic barriers, and advocacy needs.

In collaboration with cross-functional stakeholders, they will contribute to launch planning, brand strategy development, and commercial initiatives that support successful product commercialization.

This individual will help translating market insights from sources such as field feedback, market and commercial performance data into actionable recommendations and tactical plans.